ES8607357A1 - Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar - Google Patents

Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar

Info

Publication number
ES8607357A1
ES8607357A1 ES535923A ES535923A ES8607357A1 ES 8607357 A1 ES8607357 A1 ES 8607357A1 ES 535923 A ES535923 A ES 535923A ES 535923 A ES535923 A ES 535923A ES 8607357 A1 ES8607357 A1 ES 8607357A1
Authority
ES
Spain
Prior art keywords
microphase separated
controlled release
bioactive materials
blend
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535923A
Other languages
English (en)
Other versions
ES535923A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kendall Co
Original Assignee
Kendall Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kendall Co filed Critical Kendall Co
Publication of ES535923A0 publication Critical patent/ES535923A0/es
Publication of ES8607357A1 publication Critical patent/ES8607357A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C08L39/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
    • C08L39/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L57/00—Compositions of unspecified polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO DE FABRICACION DE UN GEL QUE LIBERA CONTROLADAMENTE AGENTES FARMACOLOGICOS. COMPRENDE: A) DISOLVER UN MATERIAL BIOACTIVO LIBERABLE, JUNTO CON UN COMPONENTE POLIMERO NO RETICULADO SOLUBLE EN AGUA Y UN COPOLIMERO NO RETICULADO INSOLUBLE EN AGUA, EN UN DISOLVENTE ELEGIDO ENTRE 2-METOXIETANOL, N, N-DIMETILFORMAMIDA Y METANOL; B) SEPARAR EL DISOLVENTE POR EVAPORACION, BAJO VACIO A UNA TEMPERATURA COMPRENDIDA ENTRE 60 Y 100JC; Y C) TRANSFORMAR LA MEZCLA DE HIDROGEL ASI FORMULADA, MEDIANTE EXTRUSION DE MASA FUNDIDA, MOLDEO, O COLADA EN SOLUCION, EN UN DISPOSITIVO DE LIBERACION CONTROLADA DE MATERIALES BIOACTIVOS EN EL QUE DICHOS COMPONENTES POLIMEROS, SOLUBLE EN AGUA E INSOLUBLE EN AGUA, Y DICHO MATERIAL BIOACTIVO LIBERABLE QUEDAN DISPERSOS POR TODAS PARTES SEGUN UNA MORFOLOGIA DE DOMINIOS DE MICROFASES. SIENDO: EL POLIMERO HIDROSOLUBLE, HOMOPOLIMERO DE N-VINIL-LACTAMA; Y EL INSOLUBLE, UN 50-90% EN PESO DE UN MONOMERO ETILINICAMENTE INSATURADO, UN 2-12% DE UN MONOMERO SIN GRUPOS ACIDOS E HIDROFILO. SE UTILIZA EN FARMACOLOGIA PARA APLICAR DOSIS DE EFECTO SUAVE Y CONTINUADO.
ES535923A 1983-09-15 1984-09-14 Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar Expired ES8607357A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53264383A 1983-09-15 1983-09-15
US06/606,794 US4693887A (en) 1983-09-15 1984-05-03 Microphase separated hydrogels for controlled release of bioactive materials

Publications (2)

Publication Number Publication Date
ES535923A0 ES535923A0 (es) 1986-05-16
ES8607357A1 true ES8607357A1 (es) 1986-05-16

Family

ID=27063895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535923A Expired ES8607357A1 (es) 1983-09-15 1984-09-14 Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar

Country Status (18)

Country Link
US (1) US4693887A (es)
AT (1) ATA290884A (es)
AU (1) AU577056B2 (es)
BE (1) BE900581A (es)
BR (1) BR8404409A (es)
CA (1) CA1232201A (es)
CH (1) CH666415A5 (es)
DE (1) DE3432573A1 (es)
DK (1) DK410984A (es)
ES (1) ES8607357A1 (es)
FR (1) FR2551976B1 (es)
GB (2) GB2147002B (es)
IT (1) IT1178430B (es)
NL (1) NL8402833A (es)
NO (1) NO843650L (es)
NZ (1) NZ209323A (es)
PT (1) PT79192B (es)
SE (1) SE461502B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2062900A1 (es) * 1991-07-29 1994-12-16 Univ Madrid Nac Educacion Hidrogeles de polimero heterociclico, su procedimiento de obtencion y su utilizacion como pastillas insolubles reguladoras del ph.

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
DE3517080A1 (de) * 1985-05-11 1986-11-13 Bayer Ag, 5090 Leverkusen Komponente fuer therapeutische wirkstoffabgabesysteme
IE59361B1 (en) * 1986-01-24 1994-02-09 Akzo Nv Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
US4867969A (en) * 1986-02-07 1989-09-19 Alza Corporation Hydrogel formulation for administering non-steroidal drugs
US4971790A (en) * 1986-02-07 1990-11-20 Alza Corporation Dosage form for lessening irritation of mocusa
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5133992A (en) * 1988-03-21 1992-07-28 Eastman Kodak Company Colloidally stabilized suspension process
US4931287A (en) * 1988-06-14 1990-06-05 University Of Utah Heterogeneous interpenetrating polymer networks for the controlled release of drugs
EP0347145A3 (en) * 1988-06-14 1990-10-24 University Of Utah Research Foundation Heterogeneous interpenetrating polymer networks for the controlled release of drugs
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5270358A (en) * 1989-12-28 1993-12-14 Minnesota Mining And Manufacturing Company Composite of a disperesed gel in an adhesive matrix
JP3457308B2 (ja) * 1991-11-15 2003-10-14 ミネソタ マイニング アンド マニュファクチャリング カンパニー 二相複合導性感圧接着剤の施された生物医療電極
US5352448A (en) * 1992-07-20 1994-10-04 Purdue Research Foundatioin Oral administration of antigens
DE69310887T2 (de) * 1992-07-29 1998-01-22 Baxter Int Pharmazeutische behälter und medizinische geräte mit hydrophilen, proteinverträglichen oberflächen
DE4341156C2 (de) * 1993-12-02 1997-11-13 Wacker Chemie Gmbh Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
US5840338A (en) * 1994-07-18 1998-11-24 Roos; Eric J. Loading of biologically active solutes into polymer gels
US5603955A (en) * 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
DE19622355A1 (de) * 1996-06-04 1997-12-11 Bayer Ag Formkörper die agrochemische Mittel freisetzen
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
US6566406B1 (en) 1998-12-04 2003-05-20 Incept, Llc Biocompatible crosslinked polymers
US8003705B2 (en) 1996-09-23 2011-08-23 Incept Llc Biocompatible hydrogels made with small molecule precursors
US5814329A (en) * 1996-11-12 1998-09-29 Polytherapeutics, Inc. Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents
DE19753298A1 (de) * 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE69901927T2 (de) 1998-04-27 2002-10-10 Surmodics Inc Bioaktive wirkstoffe freisetzende beschichtungen
US20020188037A1 (en) * 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
KR100978905B1 (ko) 2002-03-14 2010-08-31 가부시키가이샤 메드렉스 창상용 외용제
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US20040111144A1 (en) * 2002-12-06 2004-06-10 Lawin Laurie R. Barriers for polymeric coatings
WO2005003192A1 (en) * 2003-06-26 2005-01-13 Symyx Technologies, Inc. Synthesis of photoresist polymers
EP1667645A1 (en) * 2003-09-19 2006-06-14 Symyx Technologies Materials for enhanced delivery of hydrophilic active agents in personal care formulations
CA2563069A1 (en) 2004-04-06 2005-10-27 Surmodics, Inc. Coating compositions for bioactive agents
WO2007035954A2 (en) * 2005-09-23 2007-03-29 Duramed Pharmaceuticals, Inc. Vaginal tablets comprising misoprostol and methods of making and using the same
WO2009113972A2 (en) * 2006-02-08 2009-09-17 Tyrx Pharma, Inc. Temporarily stiffened mesh prostheses
EP2121057A4 (en) * 2007-02-06 2012-10-10 Incept Llc POLYMERIZATION WITH PRECIPITATION OF PROTEINS FOR ELUTION IN A PHYSIOLOGICAL SOLUTION
CN201075472Y (zh) * 2007-05-28 2008-06-18 富士康(昆山)电脑接插件有限公司 电连接器
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
US8745133B2 (en) * 2008-03-28 2014-06-03 Yahoo! Inc. System and method for optimizing the storage of data
CN102395401B (zh) 2009-02-12 2015-08-19 因赛普特有限责任公司 经由水凝胶塞的药物递送
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085168A (en) * 1971-02-22 1978-04-18 Cpc International Inc. Chemically joined, phase separated self-cured hydrophilic thermoplastic graft copolymers and their preparation
US4277582A (en) * 1978-03-03 1981-07-07 Ciba-Geigy Corporation Water-insoluble hydrophilic copolymers
SU806037A1 (ru) * 1978-04-06 1981-02-23 Всесоюзный Кардиологический Научныйцентр Amh Cccp Антиангинальное средство
SU1243627A3 (ru) * 1979-12-05 1986-07-07 Дзе Кендалл Компани (Фирма) Гелеобразующа композици
SE448544B (sv) * 1979-12-05 1987-03-02 Kendall & Co Vattenabsorberande komposition och anvendning derav som berare for ett lekemedel
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4423099A (en) * 1980-07-28 1983-12-27 Ciba-Geigy Corporation Membrane modified hydrogels
JPS5776046A (en) * 1980-10-27 1982-05-12 Kendall & Co Water absorbing composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2062900A1 (es) * 1991-07-29 1994-12-16 Univ Madrid Nac Educacion Hidrogeles de polimero heterociclico, su procedimiento de obtencion y su utilizacion como pastillas insolubles reguladoras del ph.

Also Published As

Publication number Publication date
PT79192B (en) 1986-08-14
NZ209323A (en) 1987-04-30
GB8620117D0 (en) 1986-10-01
AU3226884A (en) 1985-03-21
CH666415A5 (de) 1988-07-29
US4693887A (en) 1987-09-15
SE461502B (sv) 1990-02-26
FR2551976A1 (fr) 1985-03-22
NL8402833A (nl) 1985-04-01
SE8404568L (sv) 1985-03-16
ATA290884A (de) 1991-07-15
ES535923A0 (es) 1986-05-16
GB2177708A (en) 1987-01-28
PT79192A (en) 1984-10-01
GB2147002A (en) 1985-05-01
IT1178430B (it) 1987-09-09
FR2551976B1 (fr) 1988-06-10
DK410984A (da) 1985-03-16
NO843650L (no) 1985-03-18
SE8404568D0 (sv) 1984-09-12
IT8448836A0 (it) 1984-09-13
AU577056B2 (en) 1988-09-15
DE3432573A1 (de) 1985-04-18
DK410984D0 (da) 1984-08-28
GB8423416D0 (en) 1984-10-24
BE900581A (fr) 1985-03-14
GB2147002B (en) 1987-11-11
IT8448836A1 (it) 1986-03-13
CA1232201A (en) 1988-02-02
BR8404409A (pt) 1985-07-30

Similar Documents

Publication Publication Date Title
ES8607357A1 (es) Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar
US4140162A (en) Clear, autoclavable plastic formulation free of liquid plasticizers
US4968317B1 (en) Surgical materials and devices
EG20321A (en) Medical material and process for producing the same
CA2203901A1 (en) Polymeric wound healing accelerators
EP0162026A3 (en) A bacteria adsorbing composition
NZ506415A (en) Liquid polymeric compositions for controlled release of bioactive substances using a polymer to active agent ratio of less than 1:1
DE3071006D1 (en) Composition for the controlled release of an active substance and process for its preparation
PT76576B (en) Continuous release formulations
MX9706626A (es) Composiciones farmaceuticas para la liberacion controlada de receptores solubles.
CA2161903A1 (en) Polymer Composition, Absorbent Material Composition, Their Production and Use
DE3776776D1 (de) Polymerlatex mit ultrafeinen teilchen und diesen enthaltende zusammensetzungen.
WO1995024430A3 (en) Block and graft copolymers and methods relating thereto
GR3036586T3 (en) Novel hydrogels containing triblock copolymers, and preparation and use thereof
IE46085L (en) Delivery means for bioactive agents
GR3017267T3 (en) Antiacid compositions with prolonged gastric residence time.
AU651615B2 (en) Polymeric blends containing a block poly (ether-co-amide)
IL115138A (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
EP0272562A3 (en) Basic adhesive polymeric mass transmitting the active ingredient, method for making it and its use
AU8452991A (en) 1-aryl-3-pyridinyl-2-propene-1-ones
ES477787A1 (es) Un procedimiento para preparar materiales termoplasticos.
CA2133955A1 (en) Polyetheramidoamine hydrogels as heparinizable materials
AU1008692A (en) Hydrogel material
GR3026551T3 (en) Composition of polymers for medical applications.
JPS53136053A (en) Rubber composition

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990201